Screening for Incidental (Stage T1) Prostate Cancer

  • P. Guinan
Conference paper

Abstract

Screening for incidental prostate cancer means trying to diagnose T1 prostate carcinoma in men without clinically evident disease. We review here the currently available tests but focus on the only tests that are practical as well as currently in use. We evaluate cancer screening tests in general and prostate cancer screening studies in particular. Finally, we conclude with some comments on the natural history of stage T1 prostate cancer which suggest that in addition to tests with reasonable diagnostic predictive value we also need tests to determine the prognosis of a histologically diagnosed prostate cancer.

Keywords

Cadmium Adenocarcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guinan PD, Rubenstein M (1987) Methods of early diagnosis in genitourinary cancer. Cancer (Suppl) 60:668–676Google Scholar
  2. 2.
    Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. NEJM 317:909–916PubMedCrossRefGoogle Scholar
  3. 3.
    Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL (1987) Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 138:1181–1184PubMedGoogle Scholar
  4. 4.
    Perrin P, Mouriquand P, Monsallier M, Oukheira H, Maquet JH, Devonec M (1989) Hypothetical place of transrectal ultrasound in the diagnosis of prostate cancer at an early stage. J Endourol 3:109–113CrossRefGoogle Scholar
  5. 5.
    Hunter PK, Butler SA, Hodge GB, Hutchinson J (1989) Detection of prostatic cancer using transrectal ultrasound and sonographically guided biopsy in 1410 symptomatic patients. J Endourol 3:167–175CrossRefGoogle Scholar
  6. 6.
    Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Bass RB, Terry WJ, Igel TC (1989) Coordination of urosonography and prostate-specific antigen in the diagnosis of nonpalpable prostate cancer. J Endourol 3:193–199CrossRefGoogle Scholar
  7. 7.
    Kaye KW, Horwitz CA (1989) Transrectal ultrasound-guided prostate biopsies using new automatic gun: analysis of 100 consecutive cases. J Endourol 3:155–161CrossRefGoogle Scholar
  8. 8.
    Lee F, Littrup PJ, Torp-Petersen ST, et al. (1988) Prostate cancer: comparison of transrectal ultrasound and digital rectal examination for screening. Radiology 168:389–394PubMedGoogle Scholar
  9. 9.
    Cooner WH, Mosley BR, Rutherford CL Jr, et al. (1988) Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer. J Urol 139:758–761PubMedGoogle Scholar
  10. 10.
    Lee F, Schmitter SP, Torp-Pedersen ST, Chang TT, McHugh TA, Siders DB, McLeary RD (1989) Use of transrectal ultrasound in the evaluation of stage A cancer. J Endourol 3:125–135CrossRefGoogle Scholar
  11. 11.
    Andriole GL, Coplen DE (1989) Use of sonographically guided biopsy in the diagnosis of prostatic cancer in symptomatic patients. J Endourol 3:163–165CrossRefGoogle Scholar
  12. 12.
    Lee F, Torp-Pedersen ST, Littrup PJ, McLeary RD, McHugh TA, Smid AP, Stella PJ, Borlaza GS (1989) Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 170:29–32PubMedGoogle Scholar
  13. 13.
    Chodak G (1988) Transrectal ultrasonography: is it ready for routine use? JAMA 259:2744–2745PubMedCrossRefGoogle Scholar
  14. 14.
    DATTA (1988) Transrectal ultrasound in prostate cancer. JAMA 259:2757–2759CrossRefGoogle Scholar
  15. 15.
    Resnick MI (1988) Ultrasonography and prostate specific antigen in prostate cancer. J Urol 139:761Google Scholar
  16. 16.
    Miller AB, Lindsey J, Hill GB (1976) Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 17:606–612CrossRefGoogle Scholar
  17. 17.
    Dales LG, Friedman GD, Collen MF (1979) Evaluating periodic multiphasic health checkups: a controlled trial. J Chronic Dis 32:385–404PubMedCrossRefGoogle Scholar
  18. 18.
    Shapiro S, Venet W, Strax P, et al. (1982) The 14-year effect of screening in breast cancer mortality. JNCI 69:349–355PubMedGoogle Scholar
  19. 19.
    Tabor L, Faberberg CJG, et al. (1985) Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1:829–832CrossRefGoogle Scholar
  20. 20.
    Jenson CB, Shahon DB, Wangenstgeen OH (1960) Evaluation of annual examinations in the detection of cancer. JAMA 174:1783–1788PubMedGoogle Scholar
  21. 21.
    Gilbertson VA (1971) Cancer of the prostate gland. Results of early diagnosis and therapy undertaken for cure of the disease. JAMA 215:8184Google Scholar
  22. 22.
    NCI (1968) End results in cancer, report 3. US Dept of Health, Education, and Welfare, National Cancer Institute, BethesdaGoogle Scholar
  23. 23.
    Mariani AJ, Tom C, Hariharan G, Stams UK (1983) Prostate cancer: the paradox of early diagnosis. Hawaii Med J 42:3438Google Scholar
  24. 24.
    Thompson IM, Rounder JB, Teague JL, Peek M, Spence CR (1987) Impact of routine screening for adenocarcinoma of the prostate on stage distribution J Urol 137:424–426PubMedGoogle Scholar
  25. 25.
    American Cancer Society (1980) Report on the cancer-related healthy check-up. CA 30:194–240CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • P. Guinan
    • 1
  1. 1.Section for Urological OncologyCook County HospitalChicagoUSA

Personalised recommendations